The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Interleukin-6 and Cardiovascular Diseases
Open accessAbstract
Inflammatory cytokines are important for both cardiovascular scientists and practicing clinicians. Interleukin-6 (IL-6) has been emphasized by reports of elevated circulating as well as intracardiac IL-6 levels in patients with congestive heart failure (CHF). IL-6 may contribute to the progression of myocardial damage and dysfunction in chronic heart failure syndrome resulting from different causes. As the cause of CHF in cardiomyopathy, myocarditis, allograft rejection, and left ventricular assist device (LVADs) conditions, circulating IL-6 levels are associated with the severity of left ventricular dysfunction, and are also strong predictors of subsequent clinical outcomes. Continuous and excessive production of IL-6 promotes myocardial injury by breaking down both cytokine networks and viral clearance under viral myocarditis. Although IL-6 is likely important in the process of viral antigen presentation, early activation of immune responses and attenuation of viral replication also appear to be significant in an animal model of viral myocarditis. IL-6 can cause cardiac hypertrophy through the IL-6 signal transducing receptor component, glycoprotein 130. There are several interesting cases of cardiac myxoma complicated with mediastinal lymphadenopathy or left ventricular hypertrophy. Increased expression of IL-6 is observed in the myocardium of all donor hearts showing marked dysfunction. Myocardial IL-6 concentrations are also significantly higher in LVAD candidates compared with advanced heart failure patients. Although the IL-6 family plays a central role in the pathophysiology of cardiovascular diseases, it remains to be determined whether the IL-6 family is beneficial or detrimental. Future study will be needed to resolve this question.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S.-I., Nakajima, K., Koyama, K., Iwamatsu, A., et al. (1986) · Nature · doi:10.1038/324073a0 · Cited by 2,139
van der Wal, A. C., Becker, A. E., van der Loos, C. M., & Das, P. K. (1994) · Circulation · doi:10.1161/01.cir.89.1.36 · Cited by 1,910
Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?
Yudkin, J. S., Kumari, M., Humphries, S. E., & Mohamed-Ali, V. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00463-3 · Cited by 1,775
Gauldie, J., Richards, C., Harnish, D., Lansdorp, P., & Baumann, H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7251 · Cited by 1,635
Negative Inotropic Effects of Cytokines on the Heart Mediated by Nitric Oxide
Finkel, M. S., Oddis, C. V., Jacob, T. D., Watkins, S. C., Hattler, B. G., & Simmons, R. L. (1992) · Science · doi:10.1126/science.1631560 · Cited by 1,628
Pathogenetic Mechanisms of Septic Shock
Epstein, F. H., & Parrillo, J. E. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282008 · Cited by 1,548
Reynen, K. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332407 · Cited by 1,159
Role of IL-6 and Its Soluble Receptor in Induction of Chemokines and Leukocyte Recruitment
Romano, M., Sironi, M., Toniatti, C., Polentarutti, N., Fruscella, P., Ghezzi, P., Faggioni, R., Luini, W., van Hinsbergh, V., Sozzani, S., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80334-9 · Cited by 1,112
Kumar, A., Thota, V, Dee, L., Olson, J., Uretz, E., & Parrillo, J. E. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.949 · Cited by 791
Verma, S., Li, S.-H., Badiwala, M. V., Weisel, R. D., Fedak, P. W. M., Li, R.-K., Dhillon, B., & Mickle, D. A. G. (2002) · Circulation · doi:10.1161/01.cir.0000015126.83143.b4 · Cited by 634
IgG1 plasmacytosis in interleukin 6 transgenic mice
Suematsu, S., Matsuda, T., Aozasa, K., Akira, S., Nakano, N., Ohno, S., Miyazaki, J., Yamamura, K., Hirano, T., & Kishimoto, T. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7547 · Cited by 586
Tsutamoto, T., Hisanaga, T., Wada, A., Maeda, K., Ohnishi, M., Fukai, D., Mabuchi, N., Sawaki, M., & Kinoshita, M. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00494-4 · Cited by 561
Multiple actions of interleukin 6 within a cytokine network
Wong, G. G., & Clark, S. C. (1988) · Immunology Today · doi:10.1016/0167-5699(88)91200-5 · Cited by 529
Hirota, H., Yoshida, K., Kishimoto, T., & Taga, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4862 · Cited by 505
Biasucci, L. M., Liuzzo, G., Fantuzzi, G., Caligiuri, G., Rebuzzi, A. G., Ginnetti, F., Dinarello, C. A., & Maseri, A. (1999) · Circulation · doi:10.1161/01.cir.99.16.2079 · Cited by 485
Sheng, Z., Knowlton, K., Chen, J., Hoshijima, M., Brown, J. H., & Chien, K. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5783 · Cited by 394
Loppnow, H., & Libby, P. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114498 · Cited by 375
Endothelial Cell Activation by Leukocyte Microparticles
Mesri, M., & Altieri, D. C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.8.4382 · Cited by 373
Cardiotrophin-1 Activates a Distinct Form of Cardiac Muscle Cell Hypertrophy
Wollert, K. C., Taga, T., Saito, M., Narazaki, M., Kishimoto, T., Glembotski, C. C., Vernallis, A. B., Heath, J. K., Pennica, D., Wood, W. I., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9535 · Cited by 372
Gwechenberger, M., Mendoza, L. H., Youker, K. A., Frangogiannis, N. G., Smith, C. W., Michael, L. H., & Entman, M. L. (1999) · Circulation · doi:10.1161/01.cir.99.4.546 · Cited by 342
Somers, W. (1997) · The EMBO Journal · doi:10.1093/emboj/16.5.989 · Cited by 335
Protective Effects of IL-6 Blockade in Sepsis Are Linked to Reduced C5a Receptor Expression
Riedemann, N. C., Neff, T. A., Guo, R.-F., Bernacki, K. D., Laudes, I. J., Sarma, J. V., Lambris, J. D., & Ward, P. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.503 · Cited by 330
Rajavashisth, T. B., Xu, X.-P., Jovinge, S., Meisel, S., Xu, X.-O., Chai, N.-N., Fishbein, M. C., Kaul, S., Cercek, B., Sharifi, B., et al. (1999) · Circulation · doi:10.1161/01.cir.99.24.3103 · Cited by 281
Immunomodulatory therapies in sepsis
Kox, W. J., Volk, T., Kox, S. N., & Volk, H. D. (2000) · Intensive Care Medicine · doi:10.1007/s001340051129 · Cited by 256
Munger, M. A., Johnson, B., Amber, I. J., Callahan, K. S., & Gilbert, E. M. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89206-5 · Cited by 237
Antitumor activity of recombinant interleukin 6 in mice.
Mulé, J. J., McIntosh, J. K., Jablons, D. M., & Rosenberg, S. A. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.3.629 · Cited by 227
Circulating Interleukin-6 in Severe Heart Failure
MacGowan, G. A., Mann, D. L., Kormos, R. L., Feldman, A. M., & Murali, S. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00063-x · Cited by 214
Modur, V, Li, Y., Zimmerman, G. A., Prescott, S. M., & McIntyre, T. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119821 · Cited by 204
The Role of Interleukin-6 in the Failing Heart
Wollert, K. C., & Drexler, H. (2001) · Heart Failure Reviews · doi:10.1023/a:1011401825680 · Cited by 179
IFN-beta2/IL-6 augments the activity of human natural killer cells.
Luger, T., Krutmann, J., Kirnbauer, R., Urbanski, A., Schwarz, T., Klappacher, G., Köck, A., Micksche, M., Malejczyk, J., Schauer, E., et al. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.4.1206 · Cited by 150
Pathophysiological Role of Cytokines in Congestive Heart Failure
Blum, A., & Miller, H. I. (2001) · Annual Review of Medicine · doi:10.1146/annurev.med.52.1.15 · Cited by 135
Weis, M., Pehlivanli, S., Meiser, B. M., & von Scheidt, W. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01430-9 · Cited by 133
Kubota, T., Miyagishima, M., Alvarez, R., Kormos, R. L., Rosenblum, W. D., Demetris, A. J., Semigran, M. J., Dec, G. W., Holubkov, R., McTiernan, C. F., et al. (2000) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(00)00173-x · Cited by 130
Baumgarten, G., Knuefermann, P., Kalra, D. K., Gao, F., Taffet, G. E., Michael, L., Blackshear, P. J., Carballo, E., Sivasubramanian, N., & Mann, D. L. (2002) · Circulation · doi:10.1161/01.cir.0000015608.37608.18 · Cited by 127
Expression and Function of the C5a Receptor in Rat Alveolar Epithelial Cells
Riedemann, N. C., Guo, R., Sarma, V. J., Laudes, I. J., Huber-Lang, M. S., Warner, R. L., Albrecht, E. A., Speyer, C. L., & Ward, P. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1919 · Cited by 104
Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction
Raymond, R. J., DEHMER, G. J., Theoharides, T. C., & Deliargyris, E. (2001) · American Heart Journal · doi:10.1067/mhj.2001.113078 · Cited by 97
Serum interleukin-6 in congestive heart failure secondary to idiopathic dilated cardiomyopathy
Roig, E. S., Orús, J., Paré, C., Azqueta, M., Filella, X., Pérez‐Villa, F., Heras, M., & Sanz, G. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00388-9 · Cited by 96
Tanaka, T., Kanda, T., McManus, B. M., Kanai, H., Akiyama, H., Sekiguchi, K., Yokoyama, T., & Kurabayashi, M. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1428 · Cited by 93
Self-citationModification of Viral Myocarditis in Mice by Interleukin-6
Kanda, T., McManus, J. E. W., Nagai, R., Imai, S., Suzuki, T., Yang, D., McManus, B. M., & Kobayashi, I. (1996) · Circulation Research · doi:10.1161/01.res.78.5.848 · Cited by 89
Self-citationBirks, E. J., Latif, N., Owen, V. J., Bowles, C. T., Felkin, L. E., Mullen, A. J., Khaghani, A., Barton, P. J. R., Polak, J. M., Pepper, J., et al. (2001) · Circulation · doi:10.1161/hc37t1.094872 · Cited by 87
The interleukin-6/interleukin-6-receptorsystem is activated in donor hearts
Plenz, G. A. M., Eschert, H., Erren, M., Wichter, T., Böhm, M., Flesch, M., Scheld, H. H., & Deng, M. C.-H. K. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01791-6 · Cited by 86
C5a receptor and thymocyte apoptosis in sepsis
Riedemann, N. C., Guo, R., Laudes, I. J., Keller, K. A., Sarma, V. J., Padgaonkar, V. A., Zetoune, F. S., & Ward, P. A. (2002) · The FASEB Journal · doi:10.1096/fj.02-0033fje · Cited by 86
Cytokines as Emerging Targets in the Treatment of Heart Failure
Baumgarten, G., Knuefermann, P., & Mann, D. L. (2000) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(00)00063-3 · Cited by 85
Lommi, J., Pulkki, K. J., Koskinen, P., Näveri, H., Leinonen, H., Härkönen, M., & Kupari, M. M. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015142 · Cited by 75
Interleukin-6 and cardiac myxoma
Kanda, T., Umeyama, S., Sasaki, A., Nakazato, Y., Morishita, Y., Imai, S., Suzuki, T., & Murata, K. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90601-7 · Cited by 51
Self-citationThe role of nitric oxide and cytokines in heart failure
Birks, E. J., & Yacoub, M. H. (1997) · Coronary Artery Disease · doi:10.1097/00019501-199706000-00007 · Cited by 41
Deng, M. C.-H. K., Erren, M., Lütgen, A., Zimmermann, P., Brisse, B., Schmitz, W. L., Assmann, G., BREITHARDT, G. E., & Scheld, H. H. (1996) · International Journal of Cardiology · doi:10.1016/s0167-5273(96)02805-7 · Cited by 37
Alter, P. J., Hoeschen, J., Ritter, M. A., & Maisch, B. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02353-6 · Cited by 31
An Interleukin-6 Secreting Myxoma in a Hypertrophic Left Ventricle
Kanda, T., Xakajima, T., Sakamoto, H., Suzuki, T., & Murata, K. (1994) · CHEST Journal · doi:10.1378/chest.105.3.962 · Cited by 9
Self-citation
Cited by
Survival pathways in hypertrophy and heart failure: The gp130-STAT3 axis
Fischer, P., & Hilfiker-Kleiner, D. (2007) · Basic Research in Cardiology · doi:10.1007/s00395-007-0674-z · Cited by 272
Signaling Specificity of Interleukin-6 Action on Glucose and Lipid Metabolism in Skeletal Muscle
Al-Khalili, L., Bouzakri, K., Glund, S., Lönnqvist, F., Koistinen, H. A., & Krook, A. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0490 · Cited by 250
Delayed response and lack of habituation in plasma interleukin-6 to acute mental stress in men
von Känel, R., Kudielka, B. M., Preckel, D., Hanebuth, D., & Fischer, J. E. (2006) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2005.03.013 · Cited by 158
Magnavita, N., Capitanelli, I., Garbarino, S., & Pira, E. (2018) · International Archives of Occupational and Environmental Health · doi:10.1007/s00420-018-1290-y · Cited by 108
Burgeiro, A., Fuhrmann, A., Cherian, S., Espinoza, D., Jarak, I., Carvalho, R. A., Loureiro, M., Patrício, M., Antunes, M., & Carvalho, E. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00384.2015 · Cited by 76
Metadata
- Authors
- Kanda, T., & Takahashi, T.
- Venue
- Japanese Heart Journal
- Published
- 2004
- Volume
- 45
- Issue
- 2
- Pages
- 183-193
- ISSN
- 0021-4868 (ISSN-L)
- 1348-673X
- OpenAlex
- W1985076614
- Cited by
- 265
- References
- 49
- FWCI
- 9.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.